Total Visits

Views
Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study)38

Select a period of time:

Views

Views
November 20242
December 20240
January 20250
February 20250
March 202515
April 20252
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Canada1
Spain1
United Kingdom1
United States1
 

Top cities views

Views
Council Bluffs1
London1
Toronto1